Actively Recruiting
DETERMINE: Detemir vs NPH
Led by University of California, Los Angeles · Updated on 2023-09-26
336
Participants Needed
1
Research Sites
173 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of the study is to compare rates of neonatal hypoglycemia with maternal NPH vs determir use.
CONDITIONS
Official Title
DETERMINE: Detemir vs NPH
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Pregnant women with pre-existing type 2 diabetes mellitus
- Pregnant women with gestational diabetes mellitus
- Require insulin treatment to manage blood sugar during pregnancy
You will not qualify if you...
- Multiple pregnancy (twins or more)
- Diagnosis of type 1 diabetes mellitus
- Younger than 18 years old
- Known or suspected allergy to insulin detemir or NPH
- Known major fetal malformations
- Chronic kidney or liver failure
- Known positive for HIV, Hepatitis B, or Hepatitis C
- Planned early delivery due to conditions like placenta accreta or prior classical cesarean
- Insulin dependent before becoming pregnant
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of California, Los Angeles
Los Angeles, California, United States, 90069
Actively Recruiting
Research Team
M
Michael Richley, MD
CONTACT
C
Christina Han, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here